Showing results (1-10 of 54) with videos related to
Sort By:
Pageof 6
Expert Opinion on Drug Discovery|December 3, 2017
Improving the attrition rate of Lanthipeptide discovery for commercial applicationsMengxin Geng, Leif SmithApplied and Environmental Microbiology|May 20, 2018
Modifying the Lantibiotic Mutacin 1140 for Increased Yield, Activity, and StabilityMengxin Geng, Leif SmithAntimicrobial Agents and Chemotherapy|October 3, 2018
Efficacious Analogs of the Lantibiotic Mutacin 1140 against a Systemic Methicillin-Resistant Staphylococcus aureus InfectionMengxin Geng, Akshaya Ravichandran, Jerome Escano, et al.Applied and Environmental Microbiology|December 23, 2017
Covalent Structure and Bioactivity of the Type AII Lantibiotic Salivaricin A2Mengxin Geng, Frank Austin, Ronald Shin, et al.Microbiology Resource Announcements|January 15, 2019
Draft Genome Sequence of the Lantibiotic-Producing Strain Streptococcus salivarius HS0302Mengxin Geng, Peng Deng, Timothy Mire, et al.Frontiers in Microbiology|December 30, 2022
Synthesis and characterization of semisynthetic analogs of the antifungal occidiofunginMengxin Geng, Nopakorn Hansanant, Shi-En Lu, et al.Frontiers in Microbiology|January 2, 2023
Evaluation of analogs of mutacin 1140 in systemic and cutaneous methicillin-resistant Staphylococcus aureus infection models in miceMin Ju, Thushinari Joseph, Nopakorn Hansanant, et al.Antimicrobial Agents and Chemotherapy|May 28, 2020
Novel Antiparasitic Activity of the Antifungal Lead OccidiofunginJingbo Ma, Fengguang Guo, Zi Jin, et al.Applied Microbiology and Biotechnology|September 9, 2014
Algicidal activity of Bacillus sp. Lzh-5 and its algicidal compounds against Microcystis aeruginosaZhenghua Li, Mengxin Geng, Hong YangMicroorganisms|August 16, 2020
Targeting Biofilms Therapy: Current Research Strategies and Development HurdlesYu Jiang, Mengxin Geng, Liping BaiPageof 6